Anson Funds Management LP Aptevo Therapeutics Inc. Transaction History

Anson Funds Management LP

  • $839 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$15.01 - $22.16 $534,160 - $788,607
-35,587 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$21.85 - $30.0 $282,236 - $387,510
-12,917 Reduced 26.63%
35,587 $798,000
Q1 2021

May 14, 2021
BUY
$27.86 - $40.59 $84,750 - $123,474
3,042 Added 6.69%
48,504 $1.48 Million
Q4 2020

Feb 16, 2021
BUY
$6.21 - $48.36 $282,319 - $2.2 Million
45,462 New
45,462 $1.67 Million

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $1.37M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email